Vulvar HSIL
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions (NCT03937791) | National Cancer Institute (NCI) | 2019-10-09 |
Track Vulvar HSIL automatically
Every clearance here is in the API, with alerts when new ones post.